Dear Colleague, ASHM is running the Treatment of hepatitis C with Direct Acting Antivirals course at the Rydges Melbourne, Victoria on Saturday, 20 February 2016. This course is being delivered as part of the Control and Elimination within AuStralia of HEpatitis C from people living with HIV (CEASE) project in partnership with the Kirby Institute. This full […]
Category Archives: Blogs
Welcome to FixHepC, a trusted resource for those seeking effective and affordable solutions for Hepatitis C treatment. Our mission is to empower individuals with the knowledge and access to life-saving medications, ensuring that everyone has the opportunity to cure this condition. With expert guidance, patient testimonials, and up-to-date information on the latest treatments, we are here to support your journey toward a Hepatitis C-free life. Explore our resources, learn more about your treatment options, and take the first step toward a healthier future.
Our blog at FixHepC is dedicated to providing valuable insights, updates, and support for those affected by Hepatitis C. Here, you’ll find a wide range of topics, including the latest breakthroughs in Hepatitis C treatments, expert tips on managing the condition, and personal stories from individuals who have successfully undergone treatment. We also cover important health news, information on accessing affordable medications, and advice on navigating the healthcare system. Whether you’re newly diagnosed or exploring treatment options, our blog offers clear, reliable, and compassionate information to help you make informed decisions about your health.
19
Jan
Jan
A short excerpt from a recently discovered audio recording of the Rev. Dr. Martin Luther King Jr. speaking at Syracuse University in July of 1965. There are some things so dear, some things so precious, some things so eternally true that they’re worth dying for. And if a man has not discovered something that he […]
Awesome animated video of HCV life cycle.
At FixHepC our goal is to see everyone, everywhere with Hepatitis C treated with affordable DAA medications so that no man, woman or child is left behind. The target is nothing less that sending this disease to the annals of history, as was done for smallpox. Sounds impossible? Nothing is impossible (with the possible exception […]
They (who are they anyway) say, if it sounds too good to be true it probably is. If you are GT1 or GT3 then the PBS looks like it is going to come through for you (and that is 90% of all patients), however if you’re GT2 then your only option is Sofosbuvir +Ribavirin and […]
I don’t have permission to attribute this but the source is impeccable: Hi James I think we should publicise the following key features of the PBS arrangement: All patients (>=18 years) with chronic hepatitis C will be able to access treatment through PBS. No restrictions based on liver disease stage or otherwise. The PBS is […]
I’m writing this to help people understand what the recent announcement that DAA medications for HCV will be listed on the PBS. Here are a couple of links to it, both with interviews with the minister: http://www.smh.com.au/federal-politics/political-news/turnbull-government-to-spend-1-billion-on-hepatitis-c-miracle-cures-for-all-20151219-glrib0.html http://www.9news.com.au/health/2015/12/20/08/14/federal-government-to-spend-1b-to-subsidise-breakthrough-hepatitis-c-cures First let me say I think it’s fantastic that the government has committed to listing these medications because […]
08
Dec
Dec
HYDERABAD, DEC 8: Generic pharmaceutical company Hetero today announced that it has received the approval for the fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) from the Drug Controller General of India (DCGI). The drug, Ledisof, is a generic version of Gilead Sciences’ brand Harvoni which is approved by the US FDA. The Hyderabad based Hetero had signed a […]
An open letter to all members of Australian Cabinet If current medication pricing trends are allowed to continue then, when we finally invent a cure for cancer, you can almost guarantee it will be too expensive for all but the super rich to afford. Take the new Hepatitis C medication Sofosbuvir as an example. The […]
A report released Tuesday by US Senators Ron Wyden and Charles Grassley claims that Gilead Sciences priced the hepatitis C treatments Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) with the sole goal of maximising revenue. The report was based on an investigation of 20 000 pages of internal company documents, dozens of interviews with health care experts […]